202 related articles for article (PubMed ID: 35174543)
1. Downregulation of VAP-1 in OSCC suppresses tumor growth and metastasis via NF-κB/IL-8 signaling and reduces neutrophil infiltration.
Xu Q; Chen X; Yu T; Tang Q; Zhou Z; Wang H; Huang W; Huang T; Liang F
J Oral Pathol Med; 2022 Apr; 51(4):332-341. PubMed ID: 35174543
[TBL] [Abstract][Full Text] [Related]
2. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
3. CARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF-κB.
Ye LJ; Zhou XC; Yin XJ; Shang Y; Xiao Y; Jiang YL; Wen XX
Oral Dis; 2019 Nov; 25(8):1886-1896. PubMed ID: 31306536
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of HMGB1 inhibits the crosstalk between oral squamous cell carcinoma cells and tumor-associated macrophages.
Wen J; Yin P; Su Y; Gao F; Wu Y; Zhang W; Chi P; Chen J; Zhang X
Int Immunopharmacol; 2023 Jun; 119():110259. PubMed ID: 37141670
[TBL] [Abstract][Full Text] [Related]
5. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
Ma J; Na S; Wang P; Li J; He S; Liu F
Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
[No Abstract] [Full Text] [Related]
6. HMGB1-activated tumor-associated macrophages promote migration and invasion via NF-κB/IL-6 signaling in oral squamous cell carcinoma.
Jiang M; Liu L; Huang W; Qi Y; Li Y; Li B
Int Immunopharmacol; 2024 Jan; 126():111200. PubMed ID: 37988913
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
8. TGF-β1 and IL-17A comediate the protumor phenotype of neutrophils to regulate the epithelial-mesenchymal transition in oral squamous cell carcinoma.
Yu T; Tang Q; Chen X; Fan W; Zhou Z; Huang W; Liang F
J Oral Pathol Med; 2021 Apr; 50(4):353-361. PubMed ID: 33164231
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
Hu D; Zhong T; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
[TBL] [Abstract][Full Text] [Related]
11. Oral squamous cell carcinoma-derived EVs promote tumor progression by regulating inflammatory cytokines and the IL-17A-induced signaling pathway.
Li R; Zhou Y; Zhang M; Xie R; Duan N; Liu H; Qin Y; Ma J; Li Z; Ye P; Wang W; Wang X
Int Immunopharmacol; 2023 May; 118():110094. PubMed ID: 37030119
[TBL] [Abstract][Full Text] [Related]
12. lncRNA DCST1-AS1 Facilitates Oral Squamous Cell Carcinoma by Promoting M2 Macrophage Polarization through Activating NF-
Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Zou C
J Immunol Res; 2021; 2021():5524231. PubMed ID: 34414241
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
14. The role of CXCL2-mediated crosstalk between tumor cells and macrophages in Fusobacterium nucleatum-promoted oral squamous cell carcinoma progression.
Nie F; Zhang J; Tian H; Zhao J; Gong P; Wang H; Wang S; Yang P; Yang C
Cell Death Dis; 2024 Apr; 15(4):277. PubMed ID: 38637499
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor binding protein 3 promotes radiosensitivity of oral squamous cell carcinoma cells via positive feedback on NF-κB/IL-6/ROS signaling.
Wang SH; Chen YL; Hsiao JR; Tsai FY; Jiang SS; Lee AY; Tsai HJ; Chen YW
J Exp Clin Cancer Res; 2021 Mar; 40(1):95. PubMed ID: 33712045
[TBL] [Abstract][Full Text] [Related]
16. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
[TBL] [Abstract][Full Text] [Related]
17. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
Shan F; Shen S; Wang X; Chen G
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
[TBL] [Abstract][Full Text] [Related]
18. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
19. TNF-Alpha Promotes Invasion and Metastasis via NF-Kappa B Pathway in Oral Squamous Cell Carcinoma.
Tang D; Tao D; Fang Y; Deng C; Xu Q; Zhou J
Med Sci Monit Basic Res; 2017 Apr; 23():141-149. PubMed ID: 28386055
[TBL] [Abstract][Full Text] [Related]
20. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
